Lichtenberger LM et al., Phospholipid association reduces the gastric mucosal toxicity of aspirin in human subjects
In addition to the results from SURPASS 4, which was designed to provide preliminary evidence for the cardiovascular safety of tirzepatide, a separate analysis pooling all the clinical trials with tirzepatide was used to generate a pre-specified estimate of cardiovascular events [20] (Table 1)
The same result was obtained in the active controlled studies (WMD = 2.37 kg, 95% CI 0.30 to 4.44, P = 0.02, I 2 = 0%), while there is no statistically significant distinction observed between the two subgroups ( P = 0.55) (Additional file 2: Fig
What is the difference between IV therapy at a clinic versus at home in Dubai?+ Clinically identical same solutions, same DHA-licensed nurses, same medical oversight
Researchers have investigated these compounds individually for their potential roles in tissue remodeling, cellular migration, angiogenesis, vascular biology, and wound healing processes